A culture committed to putting patients first
Vice President & Managing Director, Australia & New Zealand
Tom Karalis assumed the role of Vice President & Managing Director of Australia and New Zealand in August 2017 with responsibility for Celgene’s commercial operations in the region.
Tom joined Celgene in 2011 as Director, Strategic Marketing, Asia Pacific and in 2013 assumed the role of General Manager, East Asia, a geography comprising of South Korea, Taiwan, Singapore, Hong Kong, Thailand and Malaysia. Tom first joined the pharmaceutical industry in Australia with Pharmacia, gaining experience in multiple commercial roles with increasing levels of organizational and portfolio responsibility before moving to Hong Kong as Regional Marketing Director, Asia Pacific and to South Korea as Commercial Director. Further assignments in the Asia Pacific region included General Management roles in Thailand, Vietnam and Philippines before returning to Australia to join Celgene.
Senior Finance Director, APAC
Darren Hunt has been with Celgene since 2007. Prior to becoming Senior Finance Director, ANZ, Darren oversaw the finance operations of APAC for a period of 4 years. He also spent two years in the US at Celgene Headquarters based in New Jersey which involved working on the integration teams for both Gloucester Pharmaceuticals and Abraxis Bioscience acquisitions.
From 2001 to 2007 Darren was the Finance Manager for PlantTech Pty Ltd which operated in the agricultural business. Prior to 2001 Darren worked for Iveco Trucks in numerous finance roles over a period of 12 years, including the last two years as the Financial Controller of Truckline Pty Ltd.
Darren attended Deakin University, where he completed his Bachelor of Business, Accounting in 1994. He also is a member of CPA Australia.
Senior Director, Human Resources
Mafalda Lou joined Celgene in January 2011 as Senior Director Human Resources and built our HR function within the Asia Pacific region from inception.
Mafalda has over 30 year’s experience in Human Resources Management and leadership. Her career to date has been predominantly in the Healthcare industry, including Clinical Diagnostics, Biotechnology, Medical Devices and Pharmaceutical companies such as Johnson and Johnson, Vision Systems (now known as Leica Sytems), and Dorevitch Pathology. Included in the portfolio of companies Mafalda has served are a mixture of start -up companies through to large multinational companies, where her responsibilities also ranged from Global through to Regional leadership roles. Mafalda also has extensive international experience having worked abroad for a several years in the USA, UK and Singapore.
Associate Business Unit Director, Australia & New Zealand
Jacinta has worked in the pharmaceutical industry since 1994, starting her career at Boehringer Ingelheim (4yrs) and Merck Sharp & Dohme (13yrs) prior to joining Celgene March 2010. The majority of her career has been in specialist sales, with a strong focus in the field of Haematology/Oncology. At Celgene she has managed the National Sales Haematology team, held the position of Area Manager NZ and more recently developed experience in marketing in both Australia and New Zealand.
Jacinta attended Monash University where she completed a Bachelor of Science, she has also completed the Advanced Leadership Program with Women Leadership Australia.
Associate Director, Strategic Planning, Australia & New Zealand
Alex Simpson joined Celgene in August 2009. Alex joined Celgene in a marketing role for myelodysplastic syndrome (MDS) products where he was responsible for the successful launch of Celgene’s local MDS portfolio. After 2 years Alex took on the marketing of the myeloma franchise allowing him exposure to Celgene’s full range of haematology products. During this time Alex had the opportunity to oversee several haematology market access projects for both Australia and New Zealand.
In 2013 he moved into the Australian Immunology and Inflammation Franchise as part of the start-up team.
He is currently setting up the cross franchise Strategic Planning function within Australia.
Dirk Hoenemann, MD
Medical Director, Australia & New Zealand
Dirk has approximately 10 years’ experience in experimental and clinical Haematology and Oncology. His academic appointments included the Humboldt University and Max Delbrueck Center for Molecular Medicine in Berlin, the Peter MacCallum Cancer Centre in Melbourne and the University of Wuerzburg in Germany. Through his academic experience he acted as investigator on numerous clinical trials from phase I to phase III. Prior to joining Celgene in 2010 he acted as Head of Medical Affairs for GSK Oncology in Australia.
Director, Regulatory Affairs and Compliance, Australia & New Zealand
Simon joined Celgene in August 2017 as Director, Regulatory Affairs. In July 2019, Simon’s role was expanded to include Compliance. Simon has over 14 years’ experience working in regulatory affairs across a variety of therapeutic areas, working with both small molecules and biotechnology products. He has over 26 years’ experience in the pharmaceutical industry and in that time has worked in various functional areas such as Regulatory Affairs, Health Care Compliance, Pharmacovigilance, Quality Assurance, R&D and Manufacturing.
Director of Government Affairs and Market Access, including Patient Advocacy and Corporate Communications – Australia and New Zealand
Michele has worked in the pharmaceutical industry since 2003, starting her career at GlaxoSmithKline (7 years) and ViiV Healthcare (9 years) prior to joining Celgene in February 2019. Michele has held a variety of commercial roles particularly in HIV/Immunology and more recently has held roles in global public health, government affairs, patient pathways/advocacy and health-related quality of life outcomes. She has recently returned back to Australia from working overseas for the past seven years in both the US and the UK, in local and global roles with ViiV Healthcare.
At Celgene Michele is responsible for leading Government Affairs, Market Access, Patient Advocacy, Corporate Communications and Corporate Social Responsibility. She is also a member of the Policy Scanning Working Group and Consumer Advocate Working Group for Medicines Australia. Michele trained as a registered Nurse at the Royal Melbourne Hospital, and received a Graduate Diploma from Melbourne University in Intensive Care Nursing. She has also completed her MBA at Monash University and is an active member of both university alumni programs.
For Global Leadership, please visit the Corporate Website Leadership page.